2018
DOI: 10.4103/ijo.ijo_60_18
|View full text |Cite
|
Sign up to set email alerts
|

Endogenous Cryptococcus neoformans endophthalmitis with subretinal abscess in a HIV-infected man

Abstract: To report a rare case of Cryptococcus neoformans endogenous endophthalmitis with subretinal abscess in a 36-year-old HIV-positive man, referred with progressive blurred vision in his right eye for the last 6 months. Vitreous biopsy followed by intravitreal ganciclovir did not result in significant improvement. Microbiology revealed the presence of C. neoformans, and intravitreal amphotericin B was then administered. The patient was treated aggressively with systemic and intravitreal antifungals but had a poor … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
3
2

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(2 citation statements)
references
References 13 publications
(19 reference statements)
0
2
0
Order By: Relevance
“…5,6 Candida followed by Aspergillus are the most common pathogens. 7 Endogenous cryptococcal endophthalmitis is a rarely encountered entity with a limited number of confirmed cases reported in the literature. 3,4,8 Additionally, its variable clinical manifestations both ophthalmologically and systemically can make the diagnosis difficult.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…5,6 Candida followed by Aspergillus are the most common pathogens. 7 Endogenous cryptococcal endophthalmitis is a rarely encountered entity with a limited number of confirmed cases reported in the literature. 3,4,8 Additionally, its variable clinical manifestations both ophthalmologically and systemically can make the diagnosis difficult.…”
Section: Discussionmentioning
confidence: 99%
“…[19][20][21] Several reports have described patients with cryptococcal meningitis or endophthalmitis as responsive to voriconazole after failing amphotericin and flucytosine treatment, which has been proposed to be related to superior intravitreal penetration. 7 Voriconazole administered orally reaches intravitreal concentrations of 1.0 to 1.5 mg/mL, which are well above the minimum inhibitory concentration and have no significant toxicity in concentrations up to 250 mg/mL. 22 We recommended systemic treatment per the Infectious Diseases Society of America's guidelines in conjunction with serial biweekly intravitreal amphotericin or voriconazole until clinical improvement is noted for a minimum of 6 intravitreal injections.…”
Section: Discussionmentioning
confidence: 99%